Dr Aditi Aggarwal

Research and Publication

• Deepak Gupta, Pragya Shukla, Shyam Singh Bisht, Aditi Aggarwal, Ankur Dhawan, Mohan Chand Pant, Madan Lal Bhatt, Rajeev Gupta, Kirti Srivastava, Seema Gupta & Madhu Srivastava. Comparitive study of efficacy, tolerability of four field box technique vs. two field anterior posterior technique in locally advanced carcinoma cervix: A prospective analysis.. Cancer Biology and Therapy. 05/2009; 8:9, 759-764.
• Umesh Mahantshetty, Aditi Aggarwal, Balasubramanium Ganesh, Sushama Saoba, Safoora Mulla, Reena Engineer, Supriya Chopra, Amita Maheshwari, Rajendra Kerkar, Shylasree T S, Jaya Ghosh, Sudeep Gupta, Shyamkishore Shrivasatava. Clinical Outcome of Early-Stage Endometroid Adenocarcinoma: A Tertiary Cancer Center Experience. International Journal of Gynecological Cancer .10/2013; 23(8):1446-1452.
  Aditi Aggarwal, Supriya Chopra, Siji N Paul, Reena Engineer, Shyam K Shrivastava. Evaluation of Internal Target Volume in patients undergoing Image Guided Intensity Modulated adjuvant radiation for gastric cancers. British Journal of Radiology. 11/2013; 10/1259.
• Supriya Chopra, Aditi Aggarwal, Reena Engineer, Siji Paul, Biji Thomas, Shaesta Mehta, Prachi Patil, Shailesh Shrikhande, Mahesh Goel and Shyam Shrivastava. Acute Toxicity And Compliance With Tomotherapy Based Adjuvant Intensity Modulated Radiotherapy In Patients With Gastric Cancer: Results From Prospective Study. Annals of Oncology. 2013; 24(4):iv 63.
• Supriya Chopra, Aditi Aggarwal, Reena Engineer, Tapas Dora, Biji Thomas, Supriya Sonawone, Siji N Paul, Sadhna Kannan, Prachi Patil, Shaesta Mehta, Shyam Kishore Shrivastava. IMRT is not superior to 3DCRT for adjuvant gastric cancer radiation: A matched pair analysis. JCRT.10/2015;11(3): 623-629.
• Rakesh Jalali, Jayant S GODA, Shirley Lewis, Aditi Aggarwal,Sridhar Epari, Shradha Churi, Padmavati A, Tejpal Gupta, Aliasgar Moiyadi. Impact of Oligodendroglial component in Glioblastoma (GBM-O): Is the outcome favourable than Glioblastoma?. Clinical Neurology and Neusosurgery. 8/2015; 135: 46-53.
• Sameer Rastogi, Sameer Bakshi, Aditi Aggarwal. Antiemetic Trials in Oncology: What should be done next? Natl Med J India. 29(2).Mar-Apr 2016.
  Sameer Rastogi, S V Mishra and Aditi Aggarwal. Overall Survival as Primary End Point in Advanced Soft Tissue Sarcoma and its Surrogates: A Bemusing Mirage. Sarcoma Res Int. 7/2016; 3(2): 1031.
• Roopam Srivastava, P.K. Sharma, Aditi Aggarwal, Gagan Saini. Adaptive Radiotherapy: A hybrid (on-line image guidance + off-line adaptive) approach for head and neck cancer. Poster in ESTRO 2016
• Sameer Rastogi., Aditi Aggarwal.,. Organization of Chemotherapy and Systemic Therapy Services in India: Devil lies in details. Journal of Global Oncology. 2017 ;3(2): 182-183.
• Sameer Rastogi, Aditi Aggarwal. Discordance of histo-pathological diagnosis of patients with soft tissue sarcoma referred to tertiary care center. Journal of Clinical Oncology. 2017 35:15_suppl, 11064-11064.
• Atul Sharma, Aditi Aggarwal, Ilavarasi Vanidassane et al Pazopanib toxicity in a metastatic sarcoma cohort : Are Indian patients different?. Annals of Oncology (2017) 28 (suppl_10): x149-x152. 10.1093/annonc/mdx675.
• Manyoo A Agarwal, Aditi Aggarwal, Sameer Rastogi, Hector O Ventura, Carl J Lavie.Cardiovascular Disease Burden in Cancer Patients from 2003 to 2014. European Heart Journal - Quality of Care and Clinical Outcomes, 2017;4(1): 69–70.
• Aditi Aggarwal Anurita Srivastava, Saluja S, Kishore Singh, Arun Kumar Rathi, Savita Arora. Fate of incidental gall bladder cancers: A single centre experience.,. E-poster presented at ICC 2017.
• Sameer Rastogi , Aditi Aggarwal, Akash Tiwari, Vinod Sharma. Chemotherapy in non metastatic osteosarcoma: Recent advances and implication for developing countries. Journal of Global Oncology. 2018; 4: 1-5.
• Aditi Aggarwal, Vinod Sharma, Sameer Rastogi. Adding olanzapine to three drugs anti emetic regimen: Is it time to jump the gun? IJMPO 3/2018; 39 (2):125.
  Sameer Rastogi, Aditi, Aggarwal, Ilavarasi Vanidassane Geddis Trial and Its Primary End PointThere is An Elephant in the Room! Clin Oncol. 2018; 3: 1414.
• Atul Sharma, Naresh G, Aditi Aggarwal, Adarsh Barwad, Ekta Dhamija, Rambha Panday, Venkat Sampat kumar, Anjali v Ramdulari, Sameer Rastogi . Retrospective analysis of management and outcome of advanced soft tissue sarcomas (STS) with rare histology.. J Clin Oncol 36, 2018 (suppl; abstr e23564)
• Sameer Rastogi, Atul Sharma, Aditi Aggarwal Naresh G, Adarsh Barwad, Ekta Dhamija, Rambha Panday. Outcomes of advanced soft tissue sarcoma from dedicated medical oncology sarcoma clinic in North India and evaluation of the respective model. J Clin Oncol 36, 2018 (suppl; abstre23561)
• Aditi Aggarwal, Atul Sharma, Sameer Rastogi. The quest for histology driven neoadjuvant chemotherapy in soft tissue sarcoma: end of road or just the beginning? Epub ahead of Print.2018
• Sameer Rastogi, Ekta Dhamija, Adarsh Barwad, Aditi Aggarwal, Atul Sharma, Rambha Panday. Advanced dermatofibrosarcoma protuberans treatment with imatinib - Experience from dedicated sarcoma medical oncology clinic in India . Accepted for publication in JGO June 2018
• Aparna Sharma, Ilavarasi, Adarsh Barwad, Ekta Dhamija, Aditi Aggarwal. Pazopanib toxicity in metastatic sarcoma cohort. Accepted in Indian Journal of Cancer
  Saurabh Roy, V.Subramani, Kishore Singh, Arun Kumar Rathi, Savita Arora, Aditi Aggarwal. Study of effects of Dwell Time Deviation Constraints on Inverse planning simulated annealing optimized plans of intracavitary brachytherapy of carcinoma cervix. JCRT. Epub ahead of print 2018
• Management of Gynaecological malignancies- A case based approach. Chapter in Textbook of Obstetrics and Gynaecology. A K Rathi, Aditi Aggarwal. 2018"